Literature DB >> 23377775

Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general population.

Tea Skaaby1, Lise Lotte Nystrup Husemoen, Charlotta Pisinger, Torben Jørgensen, Betina Heinsbæk Thuesen, Knud Rasmussen, Mogens Fenger, Peter Rossing, Allan Linneberg.   

Abstract

Vitamin D is associated with cardiovascular disease and renal function but the mechanisms are as yet unexplained. Microalbuminuria is associated with a higher risk of kidney function loss, cardiovascular disease, and mortality. Parathyroid hormone is a predictor of cardiovascular mortality and negatively correlated with glomerular filtration rate. We investigated the association between vitamin D status and 5-year changes in urine albumin creatinine ratio (UACR) and parathyroid hormone (PTH). A random sample of 6,784 individuals aged 30-60 years from a general population participated in the Inter99 study in 1999-2001. Vitamin D (serum-25-hydroxyvitamin D) was measured at baseline by high-performance liquid chromatography. UACR and PTH were measured at baseline and follow-up. Increased UACR was defined as UACR >4.0 mg/g reflecting the upper quartile at baseline. We included 4,330 individuals who participated at 5-year follow-up. In multivariable linear regression analysis, a 10-nmol/l higher baseline level of vitamin D was associated with a 5-year decrease in UACR by 0.92 % (95 % confidence interval, CI 0.13, 1.71). In multivariable logistic regression analysis, the odds ratio of developing increased UACR during follow-up was 0.96 (95 % CI 0.92, 0.98) per 10 nmol/l higher baseline vitamin D level. We found a significant inverse cross-sectional (p < 0.0001) but no prospective association (p = 0.6) between baseline vitamin D status and parathyroid hormone. We found low vitamin D status to be a predictor of long-term development of increased UACR. It remains to be proven whether vitamin D deficiency is a causal and reversible factor in the development of albuminuria.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377775     DOI: 10.1007/s12020-013-9887-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  36 in total

1.  A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.

Authors:  Torben Jørgensen; Knut Borch-Johnsen; Troels F Thomsen; Hans Ibsen; Charlotte Glümer; Charlotta Pisinger
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2003-10

2.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Philip Greenland; Joseph S Alpert; George A Beller; Emelia J Benjamin; Matthew J Budoff; Zahi A Fayad; Elyse Foster; Mark A Hlatky; John McB Hodgson; Frederick G Kushner; Michael S Lauer; Leslee J Shaw; Sidney C Smith; Allen J Taylor; William S Weintraub; Nanette K Wenger; Alice K Jacobs; Sidney C Smith; Jeffrey L Anderson; Nancy Albert; Christopher E Buller; Mark A Creager; Steven M Ettinger; Robert A Guyton; Jonathan L Halperin; Judith S Hochman; Frederick G Kushner; Rick Nishimura; E Magnus Ohman; Richard L Page; William G Stevenson; Lynn G Tarkington; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2010-12-14       Impact factor: 24.094

3.  Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Rachel Holden; Sarah L Booth; Caroline S Fox
Journal:  Am J Nephrol       Date:  2012-06-20       Impact factor: 3.754

4.  Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays.

Authors:  P Glendenning; M Taranto; J M Noble; A A Musk; C Hammond; P R Goldswain; W D Fraser; S D Vasikaran
Journal:  Ann Clin Biochem       Date:  2006-01       Impact factor: 2.057

5.  First morning voids are more reliable than spot urine samples to assess microalbuminuria.

Authors:  Elsbeth C Witte; Hiddo J Lambers Heerspink; Dick de Zeeuw; Stephan J L Bakker; Paul E de Jong; Ronald Gansevoort
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

6.  Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

Authors:  Dick de Zeeuw; Rajiv Agarwal; Michael Amdahl; Paul Audhya; Daniel Coyne; Tushar Garimella; Hans-Henrik Parving; Yili Pritchett; Giuseppe Remuzzi; Eberhard Ritz; Dennis Andress
Journal:  Lancet       Date:  2010-11-06       Impact factor: 79.321

7.  Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake.

Authors:  Laufey Steingrimsdottir; Orvar Gunnarsson; Olafur S Indridason; Leifur Franzson; Gunnar Sigurdsson
Journal:  JAMA       Date:  2005-11-09       Impact factor: 56.272

8.  Stability of blood (pro)vitamins during four years of storage at -20 degrees C: consequences for epidemiologic research.

Authors:  M C Ockè; J Schrijver; G L Obermann-de Boer; B P Bloemberg; G R Haenen; D Kromhout
Journal:  J Clin Epidemiol       Date:  1995-08       Impact factor: 6.437

9.  Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism.

Authors:  H Reichel; B Deibert; H Schmidt-Gayk; E Ritz
Journal:  Nephrol Dial Transplant       Date:  1991       Impact factor: 5.992

10.  Determining vitamin D status: a comparison between commercially available assays.

Authors:  Greta Snellman; Håkan Melhus; Rolf Gedeborg; Liisa Byberg; Lars Berglund; Lisa Wernroth; Karl Michaëlsson
Journal:  PLoS One       Date:  2010-07-13       Impact factor: 3.240

View more
  11 in total

1.  Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease.

Authors:  Tea Skaaby; Lise Lotte Nystrup Husemoen; Betina Heinsbæk Thuesen; Allan Linneberg
Journal:  Endocrine       Date:  2015-02-11       Impact factor: 3.633

2.  Calcium and vitamin D supplement intake may increase arterial stiffness in systemic lupus erythematosus patients.

Authors:  Susana Mellor-Pita; Pablo Tutor-Ureta; Silvia Rosado; Khusama Alkadi; Fernando Granado; Carlos Jimenez-Ortiz; Raquel Castejon
Journal:  Clin Rheumatol       Date:  2019-01-09       Impact factor: 2.980

3.  Longitudinal associations between lifestyle and vitamin D: A general population study with repeated vitamin D measurements.

Authors:  Tea Skaaby; Lise Lotte Nystrup Husemoen; Betina Heinsbæk Thuesen; Charlotta Pisinger; Anke Hannemann; Torben Jørgensen; Allan Linneberg
Journal:  Endocrine       Date:  2015-05-30       Impact factor: 3.633

4.  Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Bing-Bing Yang; Yuan-Hua Chen; Cheng Zhang; Chang-E Shi; Kai-Feng Hu; Ju Zhou; De-Xiang Xu; Xi Chen
Journal:  Endocrine       Date:  2016-10-31       Impact factor: 3.633

5.  Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival.

Authors:  Federica Saponaro; Claudio Marcocci; Riccardo Zucchi; Concetta Prontera; Aldo Clerico; Marco Scalese; Sabina Frascarelli; Alessandro Saba; Claudio Passino
Journal:  Endocrine       Date:  2017-03-23       Impact factor: 3.633

6.  Investigation of serum bisphenol A, vitamin D, and parathyroid hormone levels in patients with obstructive sleep apnea syndrome.

Authors:  Ersin Sukru Erden; Sebahat Genc; Sedat Motor; Ihsan Ustun; Kemal Turker Ulutas; Hatice Kayim Bilgic; Suleyman Oktar; Sana Sungur; Cihangir Erem; Cumali Gokce
Journal:  Endocrine       Date:  2013-08-01       Impact factor: 3.633

7.  Vitamin D and Albuminuria in Youth with and without Type 1 Diabetes.

Authors:  Debika Nandi-Munshi; Maryam Afkarian; Kathryn B Whitlock; Jamie L Crandell; Ronny A Bell; Ralph D'Agostino; Sharon Saydah; Amy K Mottl; Dana Dabelea; Mary Helen Black; Elizabeth J Mayer-Davis; Catherine Pihoker
Journal:  Horm Res Paediatr       Date:  2017-05-29       Impact factor: 2.852

8.  Carotid intima-media thickness is not associated with vitamin D and PTH levels in patients admitted to an Internal Medicine Department.

Authors:  Vincenzo Carnevale; Rita Minonne; Angela De Matthaeis; Maria Antonietta Annese; Patrizia Tabacco; Palmina D'Arcangelo; Graziella D'Amico; Alfredo Scillitani
Journal:  Endocrine       Date:  2014-02-13       Impact factor: 3.633

9.  Vitamin D status, liver enzymes, and incident liver disease and mortality: a general population study.

Authors:  Tea Skaaby; Lise Lotte Nystrup Husemoen; Anders Borglykke; Torben Jørgensen; Betina Heinsbæk Thuesen; Charlotta Pisinger; Lars Ebbe Schmidt; Allan Linneberg
Journal:  Endocrine       Date:  2013-11-23       Impact factor: 3.633

10.  Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study.

Authors:  Lian Engelen; Casper G Schalkwijk; Simone J P M Eussen; Jean L J M Scheijen; Sabita S Soedamah-Muthu; Nish Chaturvedi; John H Fuller; Coen D A Stehouwer
Journal:  Cardiovasc Diabetol       Date:  2015-05-30       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.